Source: PaxForex Premium Analytics Portal, Fundamental Insight Safe-haven assets like gold and silver can see further gains in 2021 as inflation, and inflationary pressures continue to rise. Global central banks fail to act and view inflation as transitory, while a range of indicators confirms a slowing economy. Unless this trend reverses, stagflation could take hold in 2022, extending the rally in precious metals to fresh all-time highs. The Final Japanese Leading Index for August was reported at 101.3 and the Final Japanese Coincident...
Source: PaxForex Premium Analytics Portal, Fundamental Insight UK Retail Sales for September are predicted to increase 0.5% monthly and decrease 0.4% annualized. Forex traders can compare this to UK Retail Sales for August, which decreased 0.9% monthly and increased 1.9% annualized. UK Core Retail Sales for September are predicted to increase 0.2% monthly and decrease 1.7% annualized. Forex traders can compare this to UK Core Retail Sales for August, which decreased 1.2% monthly and 0.9% annualized. The Preliminary UK Markit Manufacturing...
Source: PaxForex Premium Analytics Portal, Fundamental Insight Industrial giant 3M will publish its Q3 earnings on Oct. 26. As always, quarterly earnings reports help shape investor thinking, whether it's near-term or long-term. Unfortunately, 3M management isn't likely to give investors much good news regarding near-term trends, but what about the long-term outlook? Here's what you should know before the earnings report comes out. The case for buying 3M is based on the idea that the significant free cash flow (FCF) generated...
Source: PaxForex Premium Analytics Portal, Fundamental Insight UK Public Sector Net Borrowing for September is predicted at £14.75B. Forex traders can compare this to UK Public Sector Net Borrowing for August, reported at £19.78B. UK CBI Industrial Industrial Trends Orders for October are predicted at 18. Forex traders can compare this to CBI Industrial Trends Orders for September, reported at 22. US Initial Jobless Claims for the week of October 16th are predicted at 300K, and US Continuing Claims for the week of October 9th...
Source: PaxForex Premium Analytics Portal, Fundamental Insight In a nutshell, Johnson & Johnson's third-quarter results were generally good. The company reported a 10.7% year-over-year increase in revenue to $23.3 billion. Adjusted earnings per share rose 18.2% to $2.60, well above the consensus estimate of $2.35. Given the large earnings outperformance, you'd probably think the health care company's stock should have rallied Tuesday after the quarterly report was released. And you'd be right. J&J stock opened up...
